- Article
FABP5 Inhibition against PTEN-Mutant Therapy Resistant Prostate Cancer
- Manojit M. Swamynathan,
- Grinu Mathew,
- Andrei Aziz,
- Chris Gordon,
- Andrew Hillowe,
- Hehe Wang,
- Aashna Jhaveri,
- Jude Kendall,
- Hilary Cox and
- Lloyd C. Trotman
- + 7 authors
Resistance to standard of care taxane and androgen deprivation therapy (ADT) causes the vast majority of prostate cancer (PC) deaths worldwide. We have developed RapidCaP, an autochthonous genetically engineered mouse model of PC. It is driven by the...